\-\ Texto\\:\\ \ \(0\)\
\-\ normal\\ pap\\ and\\ pelvic\\ exam\\.\ \(0\)\
\-\ patient\\ was\\ refered\\ back\\ to\\ clinician\\ to\\ be\\ evaluated\\ for\\ endometrial\\ biopsy\ \(0\)\
\-\ on\\ transabdominal\\ ultrasound\\ imaging\\ there\\ was\\ a\\ normal\\ homogeneous\\ appearance\\ to\\ the\\ uterus\\ and\\ endometrial\\ stripe\\.\\ \\ no\\ endometrial\\ fluid\\ or\\ focal\\ areas\\ of\\ thickening\\.\\ \\ ems\\ measured\\ \\ 1\\.8\\ mm\\ consistent\\ with\\ endometrial\\ atrophy\\.\ \(0\)\
\-\ \\ \\ \\ \\ endovaginal\\ images\\ again\\ demonstrate\\ normal\\,\\ uniform\\ thickness\\ of\\ the\\ endometrial\\ stripe\\ without\\ focal\\ lesion\\.\\ \\ ems\\ measured\\ 1\\.9\\ mm\\.\ \(0\)\
\-\ \\ \\ \\ \\ hysterosonogram\\ initially\\ showed\\ no\\ focal\\ lesion\\ with\\ instillation\\ of\\ the\\ saline\\.\\ \\ after\\ balloon\\ was\\ deflated\\ a\\ small\\,\\ well\\ circumscribed\\ mass\\ was\\ identified\\ where\\ the\\ balloon\\ was\\ initially\\ sitting\\.\\ \\ this\\ lesion\\ is\\ a\\ homogeneous\\ echogenic\\ broad\\ based\\ thickening\\ of\\ the\\ endometrial\\ lining\\.\\ \\ it\\ measures\\ 5\\.1\\ x\\ 3\\.8\\ mm\\ and\\ demonstrates\\ smoothly\\ marginated\\ borders\\ without\\ cystic\\ components\\.\\ \\ the\\ cervical\\ canal\\ was\\ normal\\ in\\ appearance\\.\ \(0\)\
\-\ endometrial\\ atrophy\\ with\\ polyp\ \(0\)\
\-\ ddx\\ of\\ postmenopausal\\ bleeding\\:\ \(0\)\
\-\ 1\\)\\ \\ \\ endometrial\\ atrophy\\ \ \(0\)\
\-\ 2\\)\\ \\ \\ endometrial\\ polyp\\ \ \(0\)\
\-\ 3\\)\\ \\ \\ endometrial\\ carcinoma\ \(0\)\
\-\ 4\\)\\ \\ \\ endometrial\\ hyperplasia\ \(0\)\
\-\ 5\\)\\ \\ \\ submucosal\\ fibroid\ \(0\)\
\-\ 64\\ y\\/o\\ postmenopausal\\ female\\ with\\ new\\ onset\\ of\\ bleeding\\ starting\\ 2\\ months\\ ago\\.\\ \\ not\\ taking\\ any\\ medications\\ currently\\.\\ \\ was\\ on\\ hrt\\ for\\ 3\\ yrs\\,\\ but\\ quit\\ approximately\\ 1\\ year\\ ago\\.\\ \\ no\\ pertinent\\ family\\ history\\.\ \(0\)\
\-\ see\\ factoid\\.\ \(59\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ endometrial\\:\\ 0\\.2502229653265641\ \(0\)\
\-\ postmenopausal\\:\\ 0\\.06595078830740322\ \(0\)\
\-\ atrophy\\:\\ 0\\.062095763052144294\ \(0\)\
\-\ ems\\:\\ 0\\.056741123959875274\ \(0\)\
\-\ stripe\\:\\ 0\\.05255063473331735\ \(0\)\
\-\ balloon\\:\\ 0\\.04724252385021819\ \(0\)\
\-\ polyp\\:\\ 0\\.045673940895634466\ \(0\)\
\-\ mm\\:\\ 0\\.04425626981401416\ \(0\)\
\-\ measured\\:\\ 0\\.0435786962823555\ \(0\)\
\-\ hysterosonogram\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ deflated\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ hrt\\:\\ 0\\.04138741044115727\ \(0\)\
\-\ homogeneous\\:\\ 0\\.0379796600892097\ \(0\)\
\-\ bleeding\\:\\ 0\\.03483167089263772\ \(0\)\
\-\ focal\\:\\ 0\\.034373149354062\ \(0\)\
\-\ instillation\\:\\ 0\\.03383136390390797\ \(0\)\
\-\ initially\\:\\ 0\\.032657092434414836\ \(0\)\
\-\ was\\:\\ 0\\.03247860401641225\ \(0\)\
\-\ refered\\:\\ 0\\.031624774095242544\ \(0\)\
\-\ endovaginal\\:\\ 0\\.030577151788603065\ \(0\)\
\-\ 3\\.8\\:\\ 0\\.030577151788603065\ \(0\)\
\-\ pap\\:\\ 0\\.03012968615571891\ \(0\)\
\-\ ago\\:\\ 0\\.029865998317345058\ \(0\)\
\-\ quit\\:\\ 0\\.0297211820383967\ \(0\)\
\-\ transabdominal\\:\\ 0\\.02899746992653164\ \(0\)\
\-\ 5\\.1\\:\\ 0\\.028370561979937637\ \(0\)\
\-\ thickening\\:\\ 0\\.027198352767073726\ \(0\)\
\-\ smoothly\\:\\ 0\\.026875474040414002\ \(0\)\
\-\ saline\\:\\ 0\\.026666780319424172\ \(0\)\
\-\ lining\\:\\ 0\\.026466969923091794\ \(0\)\
\-\ 1\\.9\\:\\ 0\\.026275317366658675\ \(0\)\
\-\ clinician\\:\\ 0\\.025743257811226734\ \(0\)\
\-\ 1\\.8\\:\\ 0\\.025743257811226734\ \(0\)\
\-\ starting\\:\\ 0\\.025578509830892132\ \(0\)\
\-\ submucosal\\:\\ 0\\.02541934761645231\ \(0\)\
\-\ yrs\\:\\ 0\\.02541934761645231\ \(0\)\
\-\ normal\\:\\ 0\\.025157041400922085\ \(0\)\
\-\ fibroid\\:\\ 0\\.024831727226996888\ \(0\)\
\-\ sitting\\:\\ 0\\.02469563550458725\ \(0\)\
\-\ marginated\\:\\ 0\\.024563377866245954\ \(0\)\
\-\ lesion\\:\\ 0\\.024514862338034574\ \(0\)\
\-\ uniform\\:\\ 0\\.02351575555960647\ \(0\)\
\-\ appearance\\:\\ 0\\.022947479593752502\ \(0\)\
\-\ pertinent\\:\\ 0\\.022573639618469612\ \(0\)\
\-\ borders\\:\\ 0\\.022324297715587228\ \(0\)\
\-\ 64\\:\\ 0\\.021862137749327822\ \(0\)\
\-\ taking\\:\\ 0\\.021309165750941047\ \(0\)\
\-\ ddx\\:\\ 0\\.021180532069306705\ \(0\)\
\-\ broad\\:\\ 0\\.02081451544268834\ \(0\)\
\-\ thickness\\:\\ 0\\.0206985876840481\ \(0\)\
\-\ echogenic\\:\\ 0\\.019958545692481983\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.019766893136048857\ \(0\)\
\-\ components\\:\\ 0\\.019673923054846134\ \(0\)\
\-\ again\\:\\ 0\\.019276940012460865\ \(0\)\
\-\ 1\\:\\ 0\\.019092266365818844\ \(0\)\
\-\ uterus\\:\\ 0\\.0189109233858425\ \(0\)\
\-\ without\\:\\ 0\\.018892142407118874\ \(0\)\
\-\ 3\\:\\ 0\\.01878850259818347\ \(0\)\
\-\ evaluated\\:\\ 0\\.01839285738974454\ \(0\)\
\-\ medications\\:\\ 0\\.0178947047794415\ \(0\)\
\-\ circumscribed\\:\\ 0\\.017832106042965135\ \(0\)\
\-\ 2\\:\\ 0\\.017277976493056773\ \(0\)\
\-\ measures\\:\\ 0\\.017166493543436474\ \(0\)\
\-\ \\)\\:\\ 0\\.01674971108247195\ \(0\)\
\-\ pelvic\\:\\ 0\\.016465965852419218\ \(0\)\
\-\ family\\:\\ 0\\.01644278143157141\ \(0\)\
\-\ where\\:\\ 0\\.016373907301300082\ \(0\)\
\-\ canal\\:\\ 0\\.015938889317813204\ \(0\)\
\-\ currently\\:\\ 0\\.01589752485921154\ \(0\)\
\-\ based\\:\\ 0\\.015299015785290894\ \(0\)\
\-\ cervical\\:\\ 0\\.014577893927660228\ \(0\)\
\-\ identified\\:\\ 0\\.014335526014959256\ \(0\)\
\-\ biopsy\\:\\ 0\\.014233301603928454\ \(0\)\
\-\ factoid\\:\\ 0\\.014063077434808153\ \(0\)\
\-\ new\\:\\ 0\\.01398022524319511\ \(0\)\
\-\ areas\\:\\ 0\\.01349928249411299\ \(0\)\
\-\ back\\:\\ 0\\.01323505321759379\ \(0\)\
\-\ x\\:\\ 0\\.01323505321759379\ \(0\)\
\-\ showed\\:\\ 0\\.013154005952693412\ \(0\)\
\-\ onset\\:\\ 0\\.012663949417488968\ \(0\)\
\-\ any\\:\\ 0\\.012633028324283068\ \(0\)\
\-\ approximately\\:\\ 0\\.012412290265519169\ \(0\)\
\-\ no\\:\\ 0\\.01211893170005355\ \(0\)\
\-\ see\\:\\ 0\\.011972850756942668\ \(0\)\
\-\ ultrasound\\:\\ 0\\.011901983967165743\ \(0\)\
\-\ 5\\:\\ 0\\.011737842358892785\ \(0\)\
\-\ cystic\\:\\ 0\\.011571045573951918\ \(0\)\
\-\ fluid\\:\\ 0\\.011402061523961752\ \(0\)\
\-\ carcinoma\\:\\ 0\\.011370552441389044\ \(0\)\
\-\ 4\\:\\ 0\\.011178271855300683\ \(0\)\
\-\ y\\/o\\:\\ 0\\.011110934412298783\ \(0\)\
\-\ months\\:\\ 0\\.010957470867089519\ \(0\)\
\-\ consistent\\:\\ 0\\.009837081074324898\ \(0\)\
\-\ imaging\\:\\ 0\\.009399407626552125\ \(0\)\
\-\ small\\:\\ 0\\.009242137485357365\ \(0\)\
\-\ demonstrate\\:\\ 0\\.00923216967761991\ \(0\)\
\-\ well\\:\\ 0\\.009075497431777704\ \(0\)\
\-\ it\\:\\ 0\\.009018067533018858\ \(0\)\
\-\ exam\\:\\ 0\\.008813304882392198\ \(0\)\
\-\ demonstrates\\:\\ 0\\.00876347981996801\ \(0\)\
\-\ but\\:\\ 0\\.00855635352597905\ \(0\)\
\-\ after\\:\\ 0\\.008300475129620668\ \(0\)\
\-\ female\\:\\ 0\\.008247700804919407\ \(0\)\
\-\ images\\:\\ 0\\.007696074610090865\ \(0\)\
\-\ for\\:\\ 0\\.006846085902748499\ \(0\)\
\-\ on\\:\\ 0\\.006797098707656601\ \(0\)\
\-\ be\\:\\ 0\\.0061866512833048315\ \(0\)\
\-\ to\\:\\ 0\\.00601504378088713\ \(0\)\
\-\ there\\:\\ 0\\.005970495570258163\ \(0\)\
\-\ not\\:\\ 0\\.005797270759351809\ \(0\)\
\-\ a\\:\\ 0\\.005585912701670441\ \(0\)\
\-\ mass\\:\\ 0\\.0055796291405988945\ \(0\)\
\-\ history\\:\\ 0\\.0055409133225684665\ \(0\)\
\-\ \\:\\:\\ 0\\.005306454535167442\ \(0\)\
\-\ or\\:\\ 0\\.004701984736918814\ \(0\)\
\-\ this\\:\\ 0\\.004512381283164944\ \(0\)\
\-\ year\\:\\ 0\\.004488757132736689\ \(0\)\
\-\ patient\\:\\ 0\\.004021558361109802\ \(0\)\
\-\ the\\:\\ 0\\.003894346047989459\ \(0\)\
\-\ \\,\\:\\ 0\\.003812817824187146\ \(0\)\
\-\ of\\:\\ 0\\.003281797205577139\ \(0\)\
\-\ \\.\\:\\ 0\\.002666631819518969\ \(0\)\
\-\ is\\:\\ 0\\.002639862809317961\ \(0\)\
\-\ and\\:\\ 0\\.002535338108904485\ \(0\)\
\-\ with\\:\\ 0\\.0021972615228148308\ \(0\)\
\-\ in\\:\\ 0\\.001978390751832183\ \(0\)\
